Getson Pharmaceuticals Private Limited
About Getson Pharmaceuticals Private Limited
Data last updated:
Getson Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 24 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2020PTC366793. Its GSTIN is 07AAICG4136E1ZT (Delhi).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Swatantra Bahadur Singh and Kusum Devi.
Its last annual general meeting (AGM) was held on 25 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2 – A/3 Second Floor Kundan Manison Asaf Ali Road Turkman Gate, Delhi, India – 110002.
As per the financials filed for FY 2025, the company reported a revenue of ₹98,510, a growth of 44% compared to the previous year. For the same year it recorded a net loss of ₹4.15 Lakh (net margin -421.6%) and EBITDA of -₹4.15 Lakh (EBITDA margin -421.6%). Revenue has declined at a compounded annual rate (CAGR) of 39% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address2 – A/3 Second Floor Kundan Manison Asaf Ali Road Turkman Gate, Delhi, India – 110002
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Getson Pharmaceuticals Private Limited
The main business activity of Getson Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Getson Pharmaceuticals Private Limited FY 2025 filings available
Getson Pharmaceuticals Private Limited reported revenue of ₹98,510 (up 44% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Getson Pharmaceuticals Private Limited
Revenue rose 44% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 39%. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Getson Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹4.15 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.15 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Getson Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -421.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -421.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Getson Pharmaceuticals are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Getson Pharmaceuticals Private Limited
Getson Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Retino Pharmaceuticals Private Limited | ₹1 Lakh (FY 2025) | •••• | •••• | -69.0% | •••• | Allahabad, Uttar Pradesh, India |
| Medi Majesty Pharmaceuticals Private Limited | ₹1 Lakh (FY 2025) | •••• | •••• | -22.0% | •••• | Delhi, India |
| Kasturba Pharmaceuticals Private Limited | ₹1 Lakh (FY 2024) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Ajchem Pharmaceuticals Private Limited | ₹99,658 (FY 2024) | •••• | •••• | -69.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Nishchay Pharmaceuticals Private Limited | ₹99,532 (FY 2015) | •••• | •••• | •••• | Panchkula, Haryana, India | |
| Getson Pharmaceuticals Private Limited this company | ₹98,510 (FY 2025) | •••• | •••• | 44.0% | •••• | Delhi, India |
| Prekem Pharmaceuticals Private Limited | ₹98,410 (FY 2025) | •••• | •••• | -99.0% | •••• | Mumbai, Maharashtra, India |
| Norworth Pharmaceuticals Private Limited | ₹98,360 (FY 2019) | •••• | •••• | •••• | Raipur, Chhattisgarh, India | |
| Darovya Pharmaceuticals Private Limited | ₹98,186 (FY 2018) | •••• | •••• | •••• | Greater Noida, Uttar Pradesh, India | |
| Nivabs Pharmaceuticals Private Limited | ₹98,000 (FY 2024) | •••• | •••• | -41.0% | •••• | Rudarpur, Uttarakhand, India |
| Roykar Pharmaceuticals Private Limited | ₹97,800 (FY 2025) | •••• | •••• | -71.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Getson Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Getson Pharmaceuticals Private Limited
Getson Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swatantra Bahadur Singh | Director | 24 Jul 2020 | 6 Years 2 Months | Current |
| Kusum Devi | Director | 24 Jul 2020 | 6 Years 2 Months | Current |
Ownership and Shareholding of Getson Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Getson Pharmaceuticals Private Limited
Getson Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Getson Pharmaceuticals Private Limited
Getson Pharmaceuticals Private Limited has a workforce of 0 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Getson Pharmaceuticals Private Limited
Getson Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Kusum Devi was appointed as Director on 24 Jul 2020.
Credit Ratings, Litigation & Regulatory Alerts for Getson Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Getson Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Getson Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Getson Pharmaceuticals Private Limited
Getson Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICG4136E1ZT | Delhi | Active | 24 Sep 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Getson Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Getson Pharmaceuticals Private Limited
Getson Pharmaceuticals is an active private limited company based in Delhi, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 24 July 2020 (6+ years old) and is registered under CIN U24299DL2020PTC366793.
Getson Pharmaceuticals reported revenue of ₹98,510 for FY 2025 (up 44% YoY).
Getson Pharmaceuticals has 2 current directors:
- Swatantra Bahadur Singh - Director
- Kusum Devi - Director
Getson Pharmaceuticals reported a net loss of ₹4.15 Lakh (net margin -421.6%) and EBITDA of -₹4.15 Lakh (EBITDA margin -421.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Getson Pharmaceuticals is -39% over three years. In the latest year (FY 2025) revenue rose 44%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Getson Pharmaceuticals is 07AAICG4136E1ZT, registered in Delhi.
The CIN (Corporate Identification Number) of Getson Pharmaceuticals is U24299DL2020PTC366793. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Getson Pharmaceuticals was incorporated on 24 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Getson Pharmaceuticals by revenue are Retino Pharmaceuticals Private Limited, Medi Majesty Pharmaceuticals Private Limited, Kasturba Pharmaceuticals Private Limited, Ajchem Pharmaceuticals Private Limited, Nishchay Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Kusum Devi was appointed as Director on 24 Jul 2020. Swatantra Bahadur Singh was appointed as Director on 24 Jul 2020.
The registered office of Getson Pharmaceuticals is at 2 – A3 Second Floor Kundan Manison Asaf Ali Road Turkman Gate, Delhi, India – 110002.